IDUA Antikörper (AA 1-87) (APC)
Kurzübersicht für IDUA Antikörper (AA 1-87) (APC) (ABIN7999067)
Target
Alle IDUA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-87
-
Verwendungszweck
- Anti-IDUA Antibody APC Conjugated
-
Kreuzreaktivität (Details)
- No cross reactivity with other proteins.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human INSIG1 recombinant protein (Position: M1-R87).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Haltbarkeit
- 12 months
-
-
- IDUA (Iduronidase, alpha-L- (IDUA))
-
Andere Bezeichnung
- IDUA
-
Hintergrund
-
Background: This gene encodes an enzyme that hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. This hydrolysis is required for the lysosomal degradation of these glycosaminoglycans. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I).
Gene Full Name: alpha-L-iduronidase
-
Gen-ID
- 3425
-
UniProt
- P35475
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-